J Bone Miner Res 19:1250–1258CrossRefPubMed 6 Fraser WD, Anderso

J Bone Miner Res 19:1250–1258CrossRefPubMed 6. Fraser WD, Anderson M, Chesters C, Durham B, Ahmad AM, Chattington P, Vora J, Squire CR, Diver MJ (2001) Circadian Adriamycin nmr rhythm studies of serum bone resorption markers: implications for optimal sample timing and clinical utility. In: Eastell R, Baumann M, Hoyle NR, Wieczorek L (eds) Bone markers: biochemical and clinical

perspectives. Martin Dunitz, London, pp 107–118 7. Seibel MJ, Lang M, Geilenkeuser WJ (2001) Interlaboratory variation of biochemical markers PU-H71 of bone turnover. Clin Chem 47:1443–1450PubMed 8. Vangel MG (1996) Confidence intervals for a normal coefficient of variation. Am Stat 50:21–26CrossRef 9. Feltz CJ, Miller GE (1996) An asymptotic test for the equality of coefficients of variation from k populations. Stat Med 15:647–658CrossRef 10. Seibel MJ, Woitge HW, Farahmand VX-680 solubility dmso I, Oberwittler H, Ziegler R (1998) Automated and manual assays for urinary crosslinks of collagen: which assay to use? Exp Clin Endocrinol Diabetes 106:143–148CrossRefPubMed 11. Vesper HW, Smith SJ, Audain C, Myers GL (2001) Comparison study of urinary pyridinoline and deoxypyridinoline measurements in 13 US laboratories. Clin Chem 47:2029–2031PubMed 12. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, DeLuca HF, Drezner MK (2004) Assay variation confounds

the diagnosis of hypovitaminosis D: a call for standardization. J check Clin Endocrinol Metab 89:3152–3157CrossRefPubMed 13. Binkley N, Krueger D, Gemar D, Drezner MK (2008) Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 93:1804–1808CrossRefPubMed 14. Hollis BW (2004) The determination of circulating 25-hydroxyvitamin D: no easy task. J Clin Endocrinol Metab 89:3149–3151CrossRefPubMed 15. Tortajada-Genaro LA, Cózar MP, Frigols JL, de Avila CR (2007) Comparison of immunoradiometric assays for determination of thyroglobulin: a validation study. J Clin Lab Anal 21:147–153CrossRefPubMed 16. Holvoet P, Macy E, Landeloos

M, Jones D, Jenny NS, Van de Werf F, Tracy RP (2006) Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin Chem 52:760–764CrossRefPubMed 17. Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, Chandler W, Settlage J, Beattie MS, Folkerd E, Dowsett M, Grady D, Cummings SR (2006) Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 91:3791–3797CrossRefPubMed”
“Introduction Estrogen, the predominant female sex hormone, has commonly been considered the most important non-mechanical (endocrine) regulator of bone metabolism [1]. Estradiol esters and conjugated estrogens have strong suppressive effects on climacteric complaints, as they prevent or decelerate osteoporotic activities in the bone.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>